3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Neoplasms
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pinealoma
1
Pancreatic Cancer Metastatic
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myeloproliferative Disorders
1
Medulloblastoma
1
Leukemia, Myelomonocytic, Chronic
1
Histiocytosis, Langerhans-Cell
1
Ependymoma
1
Carcinoma
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
8
Specimen Handling
7
X-Rays
6
Phantoms, Imaging
6
Vincristine
5
Nuclear Medicine Department, Hospital
5
Cisplatin
5
Temozolomide
4
Radiotherapy
4
Biopsy
4
Lomustine
3
Etoposide
3
Carboplatin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiation
2
Platinum
2
Irinotecan
2
1,2-diaminocyclohexaneplatinum II citrate
2
tazemetostat
1
omburtamab I-131
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Medulloblastoma
×
Celecoxib
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled